Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van den Bergh, P" or (type any "bookEditor issueEditor" and editor="Van den Bergh, P")

Add to list
- Journal Article
- A1
- open access
Efficacy and safety of rozanolixizumab in moderate to severe generalized myasthenia gravis : a phase 2 randomized control trial

V Bril, M Benatar, H Andersen, J Vissing, M Brock, B Greve, P Kiessling, F Woltering, L Griffin, P Van den Bergh, et al.

(2021) NEUROLOGY. 96(6). p.E853-E865
Add to list
Efficacy and safety of Bimagrumab in sporadic inclusion body myositis : long-term extension of RESILIENT

AA Amato, MG Hanna, PM Machado, UA Badrising, H Chinoy, O Benveniste, AK Karanam, M Wu, LB Tankó, AA Schubert-Tennigkeit, et al.

(2021) NEUROLOGY. 96(12). p.e1595-e1607
Add to list
- Journal Article
- A1
- open access
Late-onset Pompe disease (LOPD) in Belgium : clinical characteristics and outcome measures

P Vanherpe, S Fieuws, A D'Hondt, C Bleyenheuft, P Demaerel, Jan De Bleecker (UGent) , P Van den Bergh, J Baets, G Remiche, K Verhoeven, et al.

(2020) ORPHANET JOURNAL OF RARE DISEASES. 15(1).
Add to list
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT) : a randomised, double-blind, placebo-controlled phase 2b trial

MG Hanna, UA Badrising, O Benveniste, TE Lloyd, M Needham, H Chinoy, M Aoki, PM Machado, C Liang, KA Reardon, et al.

(2019) LANCET NEUROLOGY. 18(9). p.834-844
Add to list
- Journal Article
- A1
- open access
Detailed α-decay study of 180Tl

B Andel, AN Andreyev, S Antalic, A Barzakh, N Bree, TE Cocolios, VF Comas, J Diriken, J Elseviers, DV Fedorov, et al.

(2017) PHYSICAL REVIEW C. 96(5).
Add to list
Database crossing allows better understanding of neuromuscular disorders epidemiology: the Belgian example

C Bleyenheuft, P Van Damme, N Goemans, Jan De Bleecker (UGent) , Rudy Van Coster (UGent) , P De Jonghe, D Beysen, P Van den Bergh, F Christiaens, A Maertens de Noordhout, et al.

(2016) NEUROMUSCULAR DISORDERS. 26(suppl. 2). p.S207-S207
Add to list
- Journal Article
- A1
- open access
β-delayed fission of 180Tl

Jytte Elseviers, Andrei N Andreyev, M Huyse, P Van Duppen, S Antalic, A Barzakh, N Bree, TE Cocolios, VF Comas, J Diriken, et al.

(2013) PHYSICAL REVIEW C. 88(4).
Add to list
Shape coexistence in 180Hg studied through the β decay of 180Tl

Jytte Elseviers, Andrei Andreyev, S Antalic, A Barzakh, N Bree, TE Cocolios, VF Comas, J Diriken, D Fedorov, VN Fedosseyev, et al.

(2011) PHYSICAL REVIEW C. 84(3).
Add to list
Mutations in SACS cause atypical and late-onset forms of ARSACS

J Baets, T Deconinck, K Smets, D Goossens, P Van Den Bergh, K Dahan, E Schmedding, Patrick Santens (UGent) , Milic V Rasic, P Van Damme, et al.

(2010) NEUROLOGY. 75(13). p.1181-1188
Add to list
- Journal Article
- A1
- open access
New type of asymmetric fission in proton-rich nuclei

AN Andreyev, J Elseviers, M Huyse, P Van Duppen, S Antalic, A Barzakh, N Bree, TE Cocolios, VF Comas, J Diriken, et al.

(2010) PHYSICAL REVIEW LETTERS. 105.
Add to list
- Journal Article
- A1
MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2

Kristien Verhoeven, KG CLAEYS, S ZUCHNER, JM SCHRODER, J WEIS, C CEUTERICK, A JORDANOVA, E NELIS, Els De Vriendt, M VAN HUL, et al.

(2006) BRAIN. 129. p.2093-2102
Add to list
- Journal Article
- A1
Necrotizing myopathy with microvascular deposition of the complement membrane attack complex

Jan De Bleecker (UGent) , Veerle Vervaet and P VAN DEN BERGH

(2004) CLINICAL NEUROPATHOLOGY. 23(2). p.76-79

Academic Bibliography

Efficacy and safety of rozanolixizumab in moderate to severe generalized myasthenia gravis : a phase 2 randomized control trial

Efficacy and safety of Bimagrumab in sporadic inclusion body myositis : long-term extension of RESILIENT

Late-onset Pompe disease (LOPD) in Belgium : clinical characteristics and outcome measures

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT) : a randomised, double-blind, placebo-controlled phase 2b trial

Detailed α-decay study of 180Tl

Database crossing allows better understanding of neuromuscular disorders epidemiology: the Belgian example

β-delayed fission of 180Tl

Shape coexistence in 180Hg studied through the β decay of 180Tl

Mutations in SACS cause atypical and late-onset forms of ARSACS

New type of asymmetric fission in proton-rich nuclei

MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2

Necrotizing myopathy with microvascular deposition of the complement membrane attack complex

Contents

Support

Contact